Cryo-EM of two polymorphic structures of alpha-synuclein fibrils by Luc Bousset and Ronald Melki from CNRS has just be published on eLife:. Read the publication.
As part of the LMB-365 project, Michel Goedert was recognised this week for 35 years at LMB (The Medical Research Council Laboratory of Molecular Biology) focussing on the study of Alzheimer’s disease, helping to show that the aggregation of tau protein is sufficient to cause neurodegeneration and dementia. LMB 365 – Day 336.
Regarding the participation of British researchers in Horizon 2020 projects, UK Research and Innovation’s (UKRI) Brussels-based UK Research Office (UKRO) is maintaining and regularly updating a factsheet providing the latest information on the current situation.
An interview of Benjamin Falcon (LMB team) entitled "Spotlight on early-career investigators: an interview with Benjamin Falcon" was published this month on Neuronet, the European network on Neurodegeneration research.
NEURONET is a three-year coordination and support action that kicked off in March 2019. The aim of NEURONET is to set up an efficient platform to boost collaboration across research projects focusing on neurodegenerative diseases, including but not limited to Alzheimer’s disease.
Enjoy browsing this new site which also links to a network of existing IMI projects in the field, amongst which IMPRiND is proud to be.
This project receives funding from the Innovative Medicines Initiative 2 Joint Undertaking (www.imi.europa.eu) under grant agreement No 116060. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
This work is supported by the Swiss State Secretariat for Education‚ Research and Innovation (SERI) under contract number 17.00038.
The opinions expressed and arguments employed herein do not necessarily reflect the official views of these funding bodies.